Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Current and Projected Market Size of the Extended-Release Drugs Industry?

The size of the market for extended-release drugs has seen a fast-paced growth in the recent past. A surge from $63.11 billion in 2024 to $69.63 billion in 2025, registering a compound annual growth rate (CAGR) of 10.3% is projected. The historical growth is linked to factors such as better patient compliance, increased prevalence of chronic diseases, enhanced efficacy, patent protection strategies, and the adoption of biodegradable implants.

Predictions indicate a swift expansion in the extended-release drugs market in the forthcoming years. An anticipated increase to “$111.26 billion by 2029 with a compound annual growth rate (CAGR) of 12.4%” is expected. The escalation during the forecast period is likely due to factors such as the adoption of personalized medicine strategies, patient-focused drug creation, an increase in lifestyle diseases, drug repurposing, and worldwide access to extended-release treatments. Key trends over the forecast period are predicted to be pharmaceutical innovation, progress in drug delivery methods, advancements in nanotechnology, the application of 3D printing in drug formulations, usage of artificial intelligence, and environmental sustainability.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12675&type=smp

#Which Factors Are Currently Driving The Growth Of The Extended-Release Drugs Market?

The anticipated growth of the extended-release drug market is primarily due to the rising prevalence of chronic diseases. Chronic diseases are typically prolonged conditions that require continuous medical attention and may limit daily activities, such as heart disease, cancer, obesity, and diabetes. Extended-release drug delivery systems are intended to keep a consistent level of medication in the body over a more extended period, ensuring a steady therapeutic effect, unlike immediate-release medicines which can cause fluctuations in drug levels. For example, the US-based National Library of Medicine, National Center for Biotechnology Information (NCBI), predicted in January 2023 that by 2050, the number of people aged 50 and above suffering from at least one chronic disease will increase by 99.5%, reaching 142.66 million. Consequently, the mounting cases of chronic ailments are propelling the growth of the extended-release drug market.

The extended-release drugs market covered in this report is segmented –

1) By Type: Sustained Release Drug, Controlled Release Drug

2) By Mode: Over-The-Counter, Prescription

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Mail Order Pharmacies, Drug Stores

Subsegments:

1) By Sustained Release Drug: Matrix Systems, Coating Systems

2) By Controlled Release Drug: Osmotic Systems, Microencapsulation Systems, Targeted Delivery Systems

Which Trends Are Redefining The Future Landscape Of The Extended-Release Drugs Industry?

The increasing trend in the extended-release drug market is product innovation. Pioneering products are being cultivated by top companies in order to maintain their market position. As a case in point, Zydus Pharmaceuticals (USA) Inc., which is a generic pharmaceutical manufacturer based in the United States, introduced Topiramate extended-release capsules for the treatment of epilepsy in July 2022. The US Food and Drug Administration (USFDA) had previously granted approval to the company to take Topiramate extended-release capsules, USP 25 mg, 50 mg, and 100 mg to market. This marks the company as the first in the nation to receive final approval and launch Topiramate extended-release capsules. Such tablets have dual approval for those dealing with partial onset or primary generalized tonic-clinic seizures.

Who Are The Main Participants Shaping The Extended-Release Drugs Market Landscape?

Major companies operating in the extended-release drugs market include Pfizer Inc., AbbVie Inc., Novartis AG, Sanofi SA, GlaxoSmithKline PLC, AstraZeneca Plc, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceuticals Inc., Eastman Chemical Company, Catalent Pharma Solutions Inc., Sun Pharmaceutical Industries Limited, Purdue Pharma LP, Amneal Pharmaceuticals Inc., Endo Pharmaceuticals Inc., Mallinckrodt LLC, Allergan plc, Hisamitsu Pharmaceutical Co. Inc., Janssen Pharmaceuticals Inc., Noven Pharmaceuticals Inc., Mayne Pharma Group Ltd., Neos Therapeutics Inc., Ardena Holding NV, UPM Pharmaceuticals Inc., Oakwood Laboratories LLC, Roxane Laboratories Inc., Lavipharm Laboratories Inc., Watson Pharmaceuticals Inc.

https://www.thebusinessresearchcompany.com/report/extended-release-drugs-global-market-report

Which Region Currently Holds The Largest Share In The Extended-Release Drugs Market?

North America was the largest region in the extended-release drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the extended-release drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12675&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model